Skip to content

Effect of Erhuang Decoction on Memory Disorder in Patients with Recurrent Mitigation Multiple Sclerosis

Effect of Erhuang Decoction on Memory Disorder in Patients with Recurrent Mitigation Multiple Sclerosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOH-17012624
Enrollment
Unknown
Registered
2017-09-08
Start date
2017-09-11
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis

Interventions

Erhuangfang treatment group:Taking Chinese medicine

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the 2010 revision of the McDonald MS diagnostic criteria; 2. Complies with MS mitigation period Features: (1) The last recurrence date has been more than 1 month; (2) The disease stabilized or tended to improve in the first 5 weeks; 3. Nuclear magnetic examination demyelinating site in the skull; 4. Aged 18 years old and elder.

Exclusion criteria

Exclusion criteria: (1) Acute MS appears to cortical state or coma; (2) Suffering from severe heart, liver, kidney dysfunction and other vital signs of vital signs; (3) Liver and kidney yin deficiency patients, the last two months by interferon, immunosuppressive agents and other immunomodulatory treatment; (4) Pregnancy or lactation; (5) There is a serious adverse reaction in the nuclear scanning, so that the examination can not continue; (6) The investigators believe that it is not appropriate to participate in any other cases of this test, such as the ability to cooperate with MRI scans; (7) During the follow-up period, the disease enters the recurrence period; (8) Accompanied by anxiety, depression, dementia and so on.

Design outcomes

Primary

MeasureTime frame
Multiple Sclerosis Quality of Life 54,MSQOL-54;Fractional Anisotropy, FA;Apparent Diffusion Coefficient, ADC;

Secondary

MeasureTime frame
Montreal Cognitive Assessment scale, MoCA;activity of daily living,ADL;Fatigue Scale-14;Pittsburgh sleep quality index,PSQI;Hamilton depression scale;Symbol Digit Modalities Test;

Countries

China

Contacts

Public ContactYongping Fan

Beijing Tiantan Hospital, Capital Medical University

yongpingf@hotmail.com+86 13520373736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026